Who is John Catanzaro
Click to play
John Catanzaro is the founder and Chief Science Officer of Neo7Bioscience, where he merges oncology, engineering, and systems biology to create personalized peptide therapeutics. His pioneering approach uses genomic mapping and molecular reprogramming to restore homeostasis and reverse chronic disease at the genetic level. With a deep background in immunology and peptide pharmacology, John’s mission is to make precision peptide medicine accessible and clinically transformative. His work is reshaping the future of anti-aging, cancer care, and chronic disease management through biologically intelligent, custom-built therapeutics.
Related Interviews
Who is Dr. Drew Taylor
Biotech scientist & founder of Acorn Biolabs, Dr. Drew Taylor leads personalized regenerative medicine by preserving your own cells and extracting the...
Featuring
Dr. Drew Taylor
Founder of Acorn Biolabs
Who is Shalin Shah
Shalin Shah is the visionary CEO of Marius Pharmaceuticals & the driving force behind KYZATREX®️, the first FDA‑approved oral testosterone therapy of ...
Featuring
Shalin Shah
CEO of Marius Pharmaceuticals